All In Biotech

Free tool

Drug Search

Every brand-name drug and biologic application (NDA or BLA) in Drugs@FDA: 5,899 in all. Generic (ANDA) applications are not listed; their reference drug is.

Last checked: Nov 20, 2026Drugs@FDA last updated: Nov 18, 2026Methods & limitations

7 matches for "Ipsen"

Brand names that start with your search come first, then marketed and novel drugs.

DrugSponsorApplicationFirst approvedPrograms
Dysport

Abobotulinumtoxina

Ipsen Biopharm LTDBLA125274Apr 29, 2009NovelOrphan
Increlex

Mecasermin Recombinant

Ipsen INCBLA021839Aug 30, 2005NovelPriority reviewOrphan
Iqirvo

Elafibranor

IpsenNDA218860Jun 10, 2024NovelBreakthrough therapyAccelerated approvalPriority reviewOrphan
Bylvay

Odevixibat

IpsenNDA215498Jul 20, 2021NovelPriority reviewOrphan
Sohonos

Palovarotene

IpsenNDA215559Aug 16, 2023NovelPriority reviewOrphan
Somatuline Depot

Lanreotide Acetate

Ipsen PharmaNDA022074Aug 30, 2007NovelOrphan
Onivyde

Irinotecan Hydrochloride

IpsenNDA207793Oct 22, 2015Priority reviewOrphan

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.